Skip to main content

Table 1 Demographic and baseline characteristics

From: Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients

Variables

Asymptomatic (N=21)

Mild (N=12)

Moderate (N=32)

Severe (N=30)

All patients (N=95)

P value

chi-square test (unless otherwise stated)

Age (years)

33.9 ± 2.4*

35.6 ± 2.7*

52.3 ± 2.1

48.8 ± 1.5

44.7 ± 1.3

*P<0.001 versus moderate and severe groups (ANOVA)

Gender (%)

 Male

8 (38.1%)

10 (83.3%)

19 (59.4%)

23 (76.7%)

60 (63.2%)

0.016

 Female

13 (61.9%)

2 (16.7%)

13 (40.6%)

7 (23.3%)

35 (36.8%)

 

Underlying diseases (%)

 Diabetes

0

0

9 (28.1%)

12 (40%)

21 (22.1%)

<0.001

 CVD

2 (9.5%)

0

13 (40.6%)

10 (33.3%)

25 (26.3%)

0.009

 Liver diseases

0

0

4 (12.5%)

9 (30%)

13 (13.7%)

0.007

 Kidney diseases

0

0

4 (12.5%)

1 (3.3%)

5 (5.3%)

0.144

 Lung diseases

0

0

3 (9.4%)

0

3 (3.2%)

0.107

 Others

0

0

3 (9.4%)

2 (6.7%)

5 (5.3%)

0.386